Acute Otitis Externa (AOE) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
_page-0001.jpg)
Acute
otitis externa (AOE), commonly called 'swimmer's ear,' is prevalent among
individuals across various age groups, including children, adolescents, and
adults. AOE is characterized by widespread inflammation of the outer ear canal,
often exacerbated by prolonged exposure to moisture and frequently associated
with swimming activities. The continuous dampness in the ear canal compromises
local defense mechanisms, leading to skin desquamation and the formation of
microscopic fissures, which serve as entry points for infectious organisms.
Various factors increase the risk of AOE, such as trauma, the presence of
foreign objects in the ear, using hearing aids, certain skin conditions,
persistent otorrhea, tight headscarves, and compromised immune systems. Even
ear piercing can predispose individuals to pinna infections. While AOE
typically remains confined to the local area, severe and invasive forms of the
disease can arise in specific circumstances. Symptoms of AOE commonly include
ear pain (otalgia), itching, a sensation of fullness, and, in some cases,
hearing impairment or discomfort in the ear canal while chewing. Many AOE
patients also experience discharge from the affected ear. Most AOE cases
involve infections predominantly caused by bacteria. Pseudomonas aeruginosa and
Staphylococcus aureus are the most frequently isolated pathogens, with
polymicrobial infections occurring in many cases. While less common, fungal
infections involving Aspergillus and Candida species have also been reported.
Topical antimicrobial agents are recommended as first-line treatment for
mild-to-moderate AOE. This typically involves a topical antibiotic, with or
without steroids, administered for seven to ten days. Severe cases may
necessitate systemic antibiotics effective against S. aureus and P. aeruginosa.
Effective pain relief for mild-to-moderate AOE can be achieved with systemic
analgesics such as acetaminophen, nonsteroidal anti-inflammatory drugs
(NSAIDs), or oral opioids. Topical steroid preparations may offer some relief
but are not recommended as standalone therapy due to inconsistent efficacy in
clinical trials. In cases where the clinician's view of the ear canal is
obstructed, an expandable wick may be inserted to reduce canal swelling and
facilitate the delivery of topical medications. While practices like aural
toileting and wick therapy are commonly employed, their effectiveness has yet
to be rigorously evaluated in randomized controlled trials. Conversely, ear
candling is ineffective and potentially harmful.
Thelansis’s “Acute Otitis Externa (AOE) Market Outlook, Epidemiology,
Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers
disease overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Acute
Otitis Externa (AOE) treatment modalities options for eight major markets (USA,
Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Acute Otitis Externa (AOE) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Acute Otitis Externa (AOE) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment